Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$2.05 - $5.5 $4.48 Million - $12 Million
-2,184,288 Reduced 50.71%
2,123,130 $5.22 Million
Q2 2022

Aug 15, 2022

BUY
$3.2 - $5.69 $6.12 Million - $10.9 Million
1,912,170 Added 79.83%
4,307,418 $20.2 Million
Q1 2022

May 16, 2022

BUY
$2.8 - $7.39 $5.36 Million - $14.1 Million
1,913,500 Added 397.2%
2,395,248 $9.89 Million
Q4 2021

Feb 14, 2022

BUY
$5.92 - $9.98 $2.85 Million - $4.81 Million
481,748 New
481,748 $3.29 Million

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Soros Capital Management LLC Portfolio

Follow Soros Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soros Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soros Capital Management LLC with notifications on news.